Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Voyager Therapeutics Inc VYGR

Healthcare Biotechnology
Voyager Therapeutics, Inc. is a biotechnology company focused on advancing neurogenetic medicines. The Company’s pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of its programs are derived from its TRACER AAV capsid discovery platform, which is used to generate novel... see more

Recent & Breaking News (NDAQ:VYGR)

VYGR Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm

GlobeNewswire January 29, 2021

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA January 28, 2021

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

PR Newswire January 27, 2021

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA January 27, 2021

Portnoy Law: Lawsuit Filed On Behalf of Voyager Therapeutics, Inc. Investors

GlobeNewswire January 26, 2021

BREAKING ALERT: ROSEN, A LEADING LAW FIRM, Encourages Voyager Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Class Action - VYGR

ACCESSWIRE IA January 26, 2021

VYGR Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm

PR Newswire January 26, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Voyager Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - VYGR

Newsfile January 26, 2021

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Voyager Therapeutics, Inc. (VYGR)

GlobeNewswire January 25, 2021

SHAREHOLDER ALERT: Holzer & Holzer Announces that a Class Action Was Filed on Behalf of Voyager Therapeutics Investors and Encourages Investors With Significant Losses to Contact the Firm

Newsfile January 25, 2021

Shareholder Alert: Robbins LLP Announces That Voyager Therapeutics, Inc. (VYGR) is Being Sued for Misleading Shareholders

Business Wire January 25, 2021

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire January 25, 2021

VYGR Investors Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Voyager Therapeutics, Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm

ACCESSWIRE IA January 25, 2021

VYGR EQUITY ALERT: Rosen Law Firm Announces Filing of Federal Securities Class Action Lawsuit Against Voyager Therapeutics, Inc. - VYGR

Business Wire January 25, 2021

Pomerantz Law Firm Announces the Filing of a Class Action against Voyager Therapeutics, Inc. and Certain Officers - VYGR

PR Newswire January 23, 2021

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 11, 2021

Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program

GlobeNewswire December 22, 2020

Solving a Critical Supply Problem for North American Pharmaceuticals

Stockhouse Editorial December 16, 2020

Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Updates

GlobeNewswire November 9, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc. - VYGR

GlobeNewswire October 21, 2020